Equilibre BioPharmaceuticals Corp.
Pharmaceutical company · New York, United States
Equilibre BioPharmaceuticals Corp. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2022.
Equilibre BioPharmaceuticals at a glance
What does Equilibre BioPharmaceuticals do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $6 million sold (2022).
Frequently asked questions about Equilibre BioPharmaceuticals
Where is Equilibre BioPharmaceuticals headquartered?
Equilibre BioPharmaceuticals Corp. is headquartered in New York, United States.
What does Equilibre BioPharmaceuticals do?
Equilibre BioPharmaceuticals Corp. is a pharmaceutical company.
When was Equilibre BioPharmaceuticals founded?
The earliest incorporation on record for Equilibre BioPharmaceuticals Corp. is in 2020, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences